Download PDF
Thromb Haemost 1977; 37(03): 572-574
DOI: 10.1055/s-0038-1649270
Letter to the Editor
Schattauer GmbH

Factor VII Concentrate

G. W. R Dike
1   Plasma Fractionation Laboratory, Churchill Hospital, Oxford, OX3 7LJ England
,
D Griffiths
1   Plasma Fractionation Laboratory, Churchill Hospital, Oxford, OX3 7LJ England
,
A. J Tadman
1   Plasma Fractionation Laboratory, Churchill Hospital, Oxford, OX3 7LJ England
› Author Affiliations
Further Information

Publication History

Publication Date:
03 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Bidwell E, Dike G. W. R. 1966. Therapeutic materials in Treatment of Haemophilia and other Coagulation Disorders . In Biggs R, Macfarlane R. G. (Eds.) Oxford: Blackwell Scientific Publications; 43
    Google Scholar
  • 2 Bidwell E, Rizza C. R, Dike G. W. R, Snape T. J. Clinical use of factor IX concentrates. Thrombosis and Haemostasis 1976; 35: 488
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Dike G. W. R, Bidwell E, Rizza C. R. The preparation and clinical use of a new concentrate containing factor IX, prothrombin and factor X and of a separate concentrate of factor VII. British Journal of Haematology. 1972; 22: 469
    PubMedGoogle Scholar
  • 4 Heystek J, Brummelhuis H. G. J, Krijnen H. W. Contributions to the optimal use of human blood II. The large-scale preparation of prothrombin complex. A comparison between two methods using the anion exchangers DEAE-Cellulose DE 52 and DEAE-Sephadex A-50. Vox Sanguinis 1973; 25: 113
    CrossrefPubMedGoogle Scholar